Blueprint Medicines Corp Cash Flow Quality Index
Blueprint Medicines Corp cash flow quality index. Blueprint Medicines Corp (BPMC) has a Cash Flow Quality Index of -109.84x as of March 2025. Operating cash flow of $-54.48 Million is below net income of $496.00K, suggesting accrual-heavy earnings not yet converted to cash. See Blueprint Medicines Corp (BPMC) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Blueprint Medicines Corp (2020–2020)
Cash flow quality index of Blueprint Medicines Corp from 2020 to 2020. Historical Cash Flow Quality Index for Blueprint Medicines Corp across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Blueprint Medicines Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Blueprint Medicines Corp Cash Flow Quality Index by Year (2020–2020)
Blueprint Medicines Corp cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for Blueprint Medicines Corp. For the full cash flow conversion analysis, see BPMC cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.23x | $387.04 Million | $313.88 Million | — |